In addition to IVIg, we have previously shown that antibodies reactive with the CD44 homing antigen can successfully ameliorate murine ITP in normal mice [32] as well as in SCID mice [7]. The gene discussed is CD44; the disease is autoimmune thrombocytopenic purpura.